Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank17
3Y CAGR+8.1%
5Y CAGR-2.3%
Year-over-Year Change

Quality of reported income

3Y CAGR
+8.1%/yr
Annual compound
5Y CAGR
-2.3%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20240.75-25.8%
20231.01+28.7%
20220.78+32.3%
20210.59-37.9%
20200.96+13.3%
20190.84-23.4%
20181.10-